Melissa West is the Project Director for the Kidney Health Initiative (KHI), a public-private partnership between the American Society of Nephrology, U.S. Food and Drug Administration and over 75 member companies and organization focused on fostering innovation and enhancing patient safety in kidney disease. Prior to joining KHI in 2012, Ms. West served as a consultant for the pharmaceutical industry coordinating their activities at scientific conferences. She was employed with Abbott Laboratories during their launch of Zemplar Capsules in 2004-2006. Her career started in the not-for-profit industry with Smith, Bucklin and Associates, including management positions with the American Society of Psychiatric Nurses, International Society of Clinical Densitometry and ending with the American Society of Nephrology. She joined the American Society of Nephrology as a full time employee in 2000 as Director of Programs with Kidney Week and assisting with corporate development. With her 16 year career in nephrology, Ms. West is please to lead the Kidney Health Initiative and ideally help facilitate the passage of drugs, device and biologics for kidney disease patients.